| P50 | author | José Julio Pacheco | Q84548172 |
| | Hassan Bousbaa | Q47503302 |
| | Luís S. Monteiro | Q51306242 |
| | Sara Ricardo | Q53231632 |
| | Maria Leonor Delgado | Q61047639 |
| P2093 | author name string | Carlos Lopes | |
| | Barbas do Amaral | |
| | Fernanda Garcez | |
| P2860 | cites work | Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: Correlation with tumor progression and patients’ prognosis | Q85046573 |
| | Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis | Q86983884 |
| | Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells | Q95793281 |
| | Global cancer statistics | Q22241238 |
| | Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system | Q33674083 |
| | High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients | Q33762138 |
| | Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia | Q33774360 |
| | Rules for making human tumor cells | Q34159004 |
| | Tumorigenic potential of extracellular matrix metalloproteinase inducer | Q35842240 |
| | CD147 immunoglobulin superfamily receptor function and role in pathology | Q36398938 |
| | Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis | Q36611964 |
| | Global epidemiology of oral and oropharyngeal cancer | Q37274268 |
| | Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. | Q37484367 |
| | CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma | Q37632989 |
| | A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma | Q37632992 |
| | Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature | Q38030130 |
| | Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells | Q39193798 |
| | EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo | Q39422403 |
| | Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma | Q39500859 |
| | High incidence of EMMPRIN expression in human tumors | Q40276050 |
| | Increased EMMPRIN (CD 147) expression during oral carcinogenesis | Q40347189 |
| | Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases | Q40434433 |
| | Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells | Q43442736 |
| | Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma | Q43616680 |
| | Prognostic significance of CD147 in patients with glioblastoma | Q43686572 |
| | EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma | Q44410097 |
| | Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. | Q44904871 |
| | EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer | Q45386247 |
| | The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. | Q45921567 |
| | EMMPRIN expression in tongue squamous cell carcinoma | Q47716522 |
| | HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection | Q47811362 |
| | Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. | Q51058959 |
| | CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. | Q54426170 |
| | Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. | Q54609532 |
| | CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis | Q58850453 |
| | Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance | Q78014467 |
| | EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology | Q83128538 |
| | Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma | Q83170873 |
| | Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas | Q83532352 |
| | High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer | Q83646062 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 905680 | |
| P577 | publication date | 2014-05-21 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival | |
| P478 | volume | 2014 | |